Literature DB >> 22395248

Effectiveness and tolerability of a polymyxin B dosing protocol.

Diana Esaian, Yanina Dubrovskaya, Michael Phillips, John Papadopoulos.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22395248     DOI: 10.1345/aph.1Q294

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  4 in total

1.  Nephrotoxicity Associated with Intravenous Polymyxin B Once- versus Twice-Daily Dosing Regimen.

Authors:  Adeola Okoduwa; Nabeela Ahmed; Yi Guo; Marco R Scipione; John Papadopoulos; Daniel P Eiras; Yanina Dubrovskaya
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

2.  Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.

Authors:  Yanina Dubrovskaya; Ting-Yi Chen; Marco R Scipione; Diana Esaian; Michael S Phillips; John Papadopoulos; Sapna A Mehta
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

3.  Does Monitoring Total and Free Polymyxin B1 Plasma Concentrations Predict Polymyxin B-Induced Nephrotoxicity? A Retrospective Study in Critically Ill Patients.

Authors:  Yang Deng; Jun-Yuan Gu; Xin Li; Huan Tong; Si-Wei Guo; Bing Xu; You Li; Bi-Kui Zhang; Ying Li; Hai-Ying Huang; Gui-Ying Xiao
Journal:  Infect Dis Ther       Date:  2022-06-11

4.  Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control Algorithm.

Authors:  Elizabeth A Lakota; Cornelia B Landersdorfer; Roger L Nation; Jian Li; Keith S Kaye; Gauri G Rao; Alan Forrest
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.